Superbugs & Superdrugs Conference 2017

We are proud to present the 2017 19th annual Superbugs & Superdrugs conference, taking place on 20th and 21st March in Central London.

Expanding horizons on the growing threat of anti-microbial resistance for almost two decades, the flagship show in the global Superbugs portfolio of events will once again play host to an international audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities.

Each year, around 2 million people are taken ill in the US from antibiotic-resistant bacteria and kills at least 23,000, according to estimates by the Centers for Disease Control and Prevention. The threat is so high that in September 2014 President Barack Obama issued an executive order Combating Antibiotic-Resistant Bacteria.

The threat is the same in Europe, big pharmaceutical companies are re-entering the space into development of new antibiotics after decades. In January 2016, more than 80 pharmaceutical, biotechnology and diagnostics companies including Roche, Pfizer, Novartis AG and GlaxoSmithKline pledged at the World Economic Forum to fight the threat of antimicrobial resistance.

The industry's premier event on antibiotic resistance will provide a perfect platform for its growing "superbugs" community to network, exchange novel solutions and consolidate current strategies. A must attend for both new and seasoned stakeholders involved in AMR and infectious disease.

Benefits of Attending

• The latest developments in antimicrobial peptides
• Ground-breaking innovations in antibacterial chemotherapy
• Comprehensive overview of government funding initiatives
• A showcase on novel approaches to enabling antibacterial activity against Gram-negative pathogens
• Guidance on antibiotic stewardship
• Updates on clinical progress
• New spotlight on animal models in drug discovery
• Hand on training through CPD certified interactive workshops

Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday 22nd March 2017

Workshop A: The Use of Animal Models in Pre-Clinical Drug Development
Workshop Leaders: William Weiss, Director, Pre-Clinical Services, UNT System College of Pharmacy
Mark Pulse, Assistant Director, Pre-Clinical Services, UNT System College of Pharmacy
08.30 - 12.30

WORKSHOP B: Practical Challenges in Developing Novel Antimicrobials
Workshop Leader: Keith Williams, Director, KW Drug Developments Ltd, ex Global Product Director
(Infection) at AstraZeneca, Hon FICR
13.30 - 17.50